Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2010-4820
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Untrusted search path vulnerability in Ghostscript 8.62 allows local users to execute arbitrary PostScript code via a Trojan horse Postscript library file in Encoding/ under the current working directory, a different vulnerability than CVE-2010-2055.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Artifex Software Ghostscript 不可信搜索路径漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Artifex Software Ghostscript是美国Artifex Software公司的一款开源的PostScript(一种用于电子产业和桌面出版领域的页面描述语言和编程语言)解析器,它可显示Postscript文件以及在非Postscript打印机上打印Postscript文件。 Artifex Software Ghostscript 8.62版本中存在不可信搜索路径漏洞。本地攻击者可借助当前工作目录下的Encoding/ URL中的Trojan horse Postscript库文件利用
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2010-4820
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2010-4820
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2010-4820

No comments yet


Leave a comment